Year archive

CF PharmTech, Inc. — 2026 filings

All 55 regulatory filings released by CF PharmTech, Inc. (2652) in 2026, sourced directly from the official regulator.

55 Filings

2026 Period

2026 filings (55)

Filing	Released	Lang
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-05-11	English
NEXT DAY DISCLOSURE RETURN Regulatory Filings	2026-05-08	English
NEXT DAY DISCLOSURE RETURN Regulatory Filings	2026-05-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026 Regulatory Filings	2026-05-07	English
NEXT DAY DISCLOSURE RETURN Regulatory Filings	2026-05-05	English
NEXT DAY DISCLOSURE RETURN Regulatory Filings	2026-05-04	English
2025 Environmental, Social and Governance Report Regulatory Filings	2026-04-30	English
2025 Annual Report Regulatory Filings	2026-04-30	English
NEXT DAY DISCLOSURE RETURN Regulatory Filings	2026-04-30	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-04-28	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-04-27	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-04-24	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-04-23	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-04-22	English
NEXT DAY DISCLOSURE RETURN Regulatory Filings	2026-04-21	English
NEXT DAY DISCLOSURE RETURN Regulatory Filings	2026-04-20	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-04-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026 Regulatory Filings	2026-04-08	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-04-02	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-04-01	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-03-31	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025 Earnings Release FY 2025	2026-03-30	English
VOLUNTARY ANNOUNCEMENT STRATEGIC COOPERATION WITH JD HEALTH Regulatory Filings	2026-03-23	English
INSIDE INFORMATION PROFIT WARNING Earnings Release FY 2025	2026-03-20	English
VOLUNTARY ANNOUNCEMENT ACCEPTANCE OF IND APPLICATION FOR ICF001 BY THE NMPA Regulatory Filings	2026-03-13	English
VOLUNTARY ANNOUNCEMENT APPROVAL OF CLINICAL TRIAL APPLICATION FOR OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE MONOHYDRATE NASAL SPRAY BY THE NMPA Regulatory Filings	2026-03-09	English
VOLUNTARY ANNOUNCEMENT INCLUSION OF THE COMPANY IN THE LIST OF ELIGIBLE SECURITIES FOR THE SHANGHAI-HONG KONG STOCK CONNECT AND SHENZHEN-HONG KONG STOCK CONNECT Regulatory Filings	2026-03-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026 Regulatory Filings	2026-03-02	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-02-27	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-02-25	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-02-24	English
VOLUNTARY ANNOUNCEMENT ACCEPTANCE OF IND APPLICATION FOR ICF004 BY THE NMPA Regulatory Filings	2026-02-23	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-02-20	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-02-16	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-02-13	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-02-12	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-02-11	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-02-10	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-02-09	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-02-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026 Share Issue/Capital Change	2026-02-05	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-02-04	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-02-03	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-02-02	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-01-30	English
VOLUNTARY ANNOUNCEMENT ACCEPTANCE OF MARKETING AUTHORIZATION APPLICATION FOR BUDESONIDE NASAL SPRAY BY THE NMPA Regulatory Filings	2026-01-29	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-01-29	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-01-28	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-01-27	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-01-26	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-01-14	English
INSIDE INFORMATION FILING WITH THE CSRC FOR PROPOSED IMPLEMENTATION OF THE H SHARE FULL CIRCULATION BY THE COMPANY Share Issue/Capital Change	2026-01-12	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-01-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025 Transaction in Own Shares	2026-01-05	English
NEXT DAY DISCLOSURE RETURN Transaction in Own Shares	2026-01-02	English